These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10609622)

  • 1. Proventil HFA prevents exercise-induced bronchoconstriction in children.
    Colice GL; Klinger NM; Ekholm BP; Dockhorn RJ
    J Asthma; 1999 Dec; 36(8):671-6. PubMed ID: 10609622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin.
    Dockhorn RJ; Wagner DE; Burgess GL; Hafner KB; Letourneau K; Colice GL; Klinger NM
    Ann Allergy Asthma Immunol; 1997 Jul; 79(1):85-8. PubMed ID: 9236507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
    Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma.
    Shapiro GS; Klinger NM; Ekholm BP; Colice GL
    J Asthma; 2000 Dec; 37(8):667-75. PubMed ID: 11192231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
    Bleecker ER; Tinkelman DG; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
    Chest; 1998 Feb; 113(2):283-9. PubMed ID: 9498940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of long-term treatment with HFA albuterol.
    Ramsdell JW; Klinger NM; Ekholm BP; Colice GL
    Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm.
    Pearlman DS; Rees W; Schaefer K; Huang H; Andrews WT
    J Asthma; 2007 Nov; 44(9):729-33. PubMed ID: 17994402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
    Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
    Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.
    Ostrom NK; Taveras H; Iverson H; Pearlman DS
    Respir Med; 2015 Nov; 109(11):1410-5. PubMed ID: 26475054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
    Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children.
    Pearlman D; Milgrom H; Till D; Ziehmer B
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):382-8. PubMed ID: 17042146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm.
    Kemp JP; Dockhorn RJ; Busse WW; Bleecker ER; Van As A
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1612-5. PubMed ID: 7952623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB; Rosario N; Aristizabal G; Loeys T; Noonan G; Gaile S; Smugar SS; Polos PG
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):511-7. PubMed ID: 20568384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
    Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H
    Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH; Harkins M; Kelly F; Kelly HW
    Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of caffeine and albuterol on the bronchoconstrictor response to exercise in asthmatic athletes.
    VanHaitsma TA; Mickleborough T; Stager JM; Koceja DM; Lindley MR; Chapman R
    Int J Sports Med; 2010 Apr; 31(4):231-6. PubMed ID: 20148372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.